Logo image of INVZ

INNOVIZ TECHNOLOGIES LTD (INVZ) Stock Fundamental Analysis

NASDAQ:INVZ - Nasdaq - IL0011745804 - Common Stock - Currency: USD

0.941  +0.02 (+2.06%)

After market: 0.94 0 (-0.11%)

Fundamental Rating

4

Overall INVZ gets a fundamental rating of 4 out of 10. We evaluated INVZ against 125 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for INVZ as it has an excellent financial health rating, but there are worries on the profitability. INVZ is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

INVZ had negative earnings in the past year.
In the past year INVZ has reported a negative cash flow from operations.
In the past 5 years INVZ always reported negative net income.
In the past 5 years INVZ always reported negative operating cash flow.
INVZ Yearly Net Income VS EBIT VS OCF VS FCFINVZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

The Return On Assets of INVZ (-49.17%) is worse than 85.60% of its industry peers.
INVZ has a Return On Equity of -71.69%. This is amonst the worse of the industry: INVZ underperforms 81.60% of its industry peers.
Industry RankSector Rank
ROA -49.17%
ROE -71.69%
ROIC N/A
ROA(3y)-59.25%
ROA(5y)-67.39%
ROE(3y)-88.89%
ROE(5y)-96.81%
ROIC(3y)N/A
ROIC(5y)N/A
INVZ Yearly ROA, ROE, ROICINVZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

With a Gross Margin value of 20.57%, INVZ is not doing good in the industry: 61.60% of the companies in the same industry are doing better.
INVZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INVZ Yearly Profit, Operating, Gross MarginsINVZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K

7

2. Health

2.1 Basic Checks

INVZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
INVZ has more shares outstanding than it did 1 year ago.
INVZ has more shares outstanding than it did 5 years ago.
There is no outstanding debt for INVZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INVZ Yearly Shares OutstandingINVZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
INVZ Yearly Total Debt VS Total AssetsINVZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -5.27, we must say that INVZ is in the distress zone and has some risk of bankruptcy.
INVZ has a Altman-Z score of -5.27. This is amonst the worse of the industry: INVZ underperforms 91.20% of its industry peers.
There is no outstanding debt for INVZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.27
ROIC/WACCN/A
WACC9.02%
INVZ Yearly LT Debt VS Equity VS FCFINVZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

INVZ has a Current Ratio of 4.30. This indicates that INVZ is financially healthy and has no problem in meeting its short term obligations.
INVZ has a better Current ratio (4.30) than 77.60% of its industry peers.
INVZ has a Quick Ratio of 4.23. This indicates that INVZ is financially healthy and has no problem in meeting its short term obligations.
INVZ has a Quick ratio of 4.23. This is amongst the best in the industry. INVZ outperforms 81.60% of its industry peers.
Industry RankSector Rank
Current Ratio 4.3
Quick Ratio 4.23
INVZ Yearly Current Assets VS Current LiabilitesINVZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.26% over the past year.
The Revenue has grown by 28.50% in the past year. This is a very strong growth!
INVZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 72.69% yearly.
EPS 1Y (TTM)40.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.11%
Revenue 1Y (TTM)28.5%
Revenue growth 3Y64.32%
Revenue growth 5Y72.69%
Sales Q2Q%146.42%

3.2 Future

INVZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.08% yearly.
Based on estimates for the next years, INVZ will show a very strong growth in Revenue. The Revenue will grow by 133.33% on average per year.
EPS Next Y37.82%
EPS Next 2Y20.96%
EPS Next 3Y17.33%
EPS Next 5Y46.08%
Revenue Next Year132.98%
Revenue Next 2Y130.75%
Revenue Next 3Y102.1%
Revenue Next 5Y133.33%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVZ Yearly Revenue VS EstimatesINVZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 500M 1B 1.5B 2B
INVZ Yearly EPS VS EstimatesINVZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

0

4. Valuation

4.1 Price/Earnings Ratio

INVZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year INVZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INVZ Price Earnings VS Forward Price EarningsINVZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INVZ Per share dataINVZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

INVZ's earnings are expected to grow with 17.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.96%
EPS Next 3Y17.33%

0

5. Dividend

5.1 Amount

No dividends for INVZ!.
Industry RankSector Rank
Dividend Yield N/A

INNOVIZ TECHNOLOGIES LTD

NASDAQ:INVZ (6/11/2025, 8:00:02 PM)

After market: 0.94 0 (-0.11%)

0.941

+0.02 (+2.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners24.35%
Inst Owner Change-2.07%
Ins Owners1.72%
Ins Owner ChangeN/A
Market Cap187.22M
Analysts80
Price Target2.45 (160.36%)
Short Float %11.61%
Short Ratio7.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.23%
Min EPS beat(2)20.7%
Max EPS beat(2)27.76%
EPS beat(4)3
Avg EPS beat(4)14.51%
Min EPS beat(4)-6.56%
Max EPS beat(4)27.76%
EPS beat(8)5
Avg EPS beat(8)7.13%
EPS beat(12)7
Avg EPS beat(12)4.74%
EPS beat(16)7
Avg EPS beat(16)-21.73%
Revenue beat(2)2
Avg Revenue beat(2)26.19%
Min Revenue beat(2)0.84%
Max Revenue beat(2)51.55%
Revenue beat(4)3
Avg Revenue beat(4)23.44%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)51.55%
Revenue beat(8)7
Avg Revenue beat(8)24.67%
Revenue beat(12)7
Avg Revenue beat(12)4.99%
Revenue beat(16)8
Avg Revenue beat(16)-2.75%
PT rev (1m)3.59%
PT rev (3m)-12.16%
EPS NQ rev (1m)2.7%
EPS NQ rev (3m)28.57%
EPS NY rev (1m)4.79%
EPS NY rev (3m)32.39%
Revenue NQ rev (1m)-16.28%
Revenue NQ rev (3m)-47.92%
Revenue NY rev (1m)3.1%
Revenue NY rev (3m)0.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.41
P/FCF N/A
P/OCF N/A
P/B 1.74
P/tB 1.74
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0.17
BVpS0.54
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -49.17%
ROE -71.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.57%
FCFM N/A
ROA(3y)-59.25%
ROA(5y)-67.39%
ROE(3y)-88.89%
ROE(5y)-96.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 77.65%
Cap/Sales 14.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.3
Quick Ratio 4.23
Altman-Z -5.27
F-Score5
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)143.46%
Cap/Depr(5y)143.66%
Cap/Sales(3y)141.33%
Cap/Sales(5y)109.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.11%
EPS Next Y37.82%
EPS Next 2Y20.96%
EPS Next 3Y17.33%
EPS Next 5Y46.08%
Revenue 1Y (TTM)28.5%
Revenue growth 3Y64.32%
Revenue growth 5Y72.69%
Sales Q2Q%146.42%
Revenue Next Year132.98%
Revenue Next 2Y130.75%
Revenue Next 3Y102.1%
Revenue Next 5Y133.33%
EBIT growth 1Y35.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.39%
EBIT Next 3Y9.19%
EBIT Next 5Y20.26%
FCF growth 1Y31.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.85%
OCF growth 3YN/A
OCF growth 5YN/A